Sanitizer Demand Sparks Creativity: Compressed-Air Spray, ‘Shield’ Formula, Single-Use Convenience
Executive Summary
COVID-19 drives hand sanitizer innovation as firms look to solve typical problems such as short microbe-kill treatment periods or risk of infection from sharing sanitizer bottles. Among launches, Breathe aerosol hand sanitizers use compressed air for faster application withouontact, while Disinfectant&Shield claims to kill germs for eight hours.
You may also be interested in...
US FDA's Consumer Health Oversight Absent From Appropriators’ Request For COVID-19 Assessment
House appropriators don’t mention the consumer health market in requesting a report on FDA’s response to COVID-19, but the agency’s frequent warnings about products marketed with unlawful claims could merit mentioning. Encouraging accelerated production of hand sanitizers while also ensuring the additional supplies are safe is another component of its COVID-19 response that could be covered in an assessment of its response to the pandemic.
Guidance Opening Sanitizer Production Stirs Firms Including Anheuser-Busch, Dow, Kodak
Dow Chemical, Anheuser-Busch and Kodak designate manufacturing for hand sanitizers and donate products to fight COVID-19. Dow is making up to 15 tons of sanitizer a day while Kodak donates formulas to New York's “NYS Clean” sanitizer distribution program.
US Consumers' Hand Sanitizer Resources Expand: FDA Allows Compounding During Pandemic
Agency says compounding pharmacies are more familiar with standards and methods for producing drug products than “untrained consumers.” It will allow operations that might otherwise get sanctioned for marketing adulterated drugs because their products likely are better than some remedies consumers are making. It is aware consumers are experiencing difficulties accessing alcohol-based hand sanitizers and are concocting their own hand sanitizers.